4/A: Teleflex CEO Liam Kelly Receives Stock Options and Restricted Stock Units
SEC Form 4/A (Amendment to Statement of Changes in Beneficial Ownership)
Teleflex's CEO, Liam Kelly, received stock options and restricted stock units, with a correction made to a previous filing regarding the number of shares in the restricted stock unit award.
Summary
- Liam Kelly, the Chairman, President, and CEO of Teleflex Inc., received a Restricted Stock Unit Award and stock options on February 27, 2024.
- The Restricted Stock Unit Award was granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan and vests 100% on the third anniversary of the grant date.
- An amendment was filed to correct the number of shares underlying Mr. Kelly's Restricted Stock Unit Award from 6787 to 6858.
- Kelly also received stock options for 48,094 shares at an exercise price of $226.04, which are exercisable in three equal installments on February 27, 2025, February 27, 2026, and February 27, 2027.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which are generally viewed neutrally to positively as they align management interests with shareholders. The correction of the share count is a minor issue and doesn't significantly impact sentiment.
Positives
- The grant of stock options and restricted stock units aligns the CEO's interests with those of the shareholders.
- The vesting schedule of the stock options and restricted stock units encourages long-term performance.
Industry Context
Equity compensation is a common practice in publicly traded companies to incentivize executives and align their interests with shareholders. The specific terms of the grants, such as vesting schedules and exercise prices, are tailored to the company's performance goals and industry standards.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the medical device industry, often benchmarked against peer companies like Medtronic, Boston Scientific, and Abbott.
- Vesting schedules, such as the three-year vesting period for the Restricted Stock Units, are typical to encourage long-term commitment and performance.
- The size of the grant is likely determined by Teleflex's compensation committee based on factors such as company performance, executive contribution, and market data for similar roles.
Stakeholder Impact
- Shareholders: The equity grants aim to align management's interests with shareholder value creation.
- Employees: The grants can serve as a signal of confidence in the company's future prospects.
- Management: The grants provide incentives for achieving long-term strategic goals.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of the transaction (grant of Restricted Stock Unit Award and stock options). |
| 02/27/2025 | First date that one-third of the stock options become exercisable. |
| 02/27/2026 | Second date that one-third of the stock options become exercisable. |
| 02/27/2027 | Third date that one-third of the stock options become exercisable. |
| 02/27/2034 | Expiration date of the stock options. |
| 06/20/2024 | Date of the signature on the form. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.